Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDKyntra Bio Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$3.84 | -$2.86 | -$3.36 |
| Q2 2026 | 2 | -$3.62 | -$2.92 | -$3.27 |
| Q3 2026 | 2 | -$3.86 | -$2.89 | -$3.38 |
| Q4 2026 | 1 | -$4.39 | -$2.63 | -$3.51 |
| Q1 2027 | 1 | -$3.55 | -$2.12 | -$2.84 |
| Q2 2027 | 1 | -$3.81 | -$2.28 | -$3.05 |
| Q3 2027 | 1 | -$3.78 | -$2.26 | -$3.02 |
| Q4 2027 | 1 | -$3.74 | -$2.24 | -$2.99 |
| Q1 2028 | 1 | -$3.70 | -$2.21 | -$2.96 |
| Q2 2028 | 1 | -$3.67 | -$2.19 | -$2.93 |
| Q3 2028 | 1 | -$3.63 | -$2.17 | -$2.90 |
| Q4 2028 | 1 | -$3.60 | -$2.15 | -$2.87 |
Kyntra Bio Inc. Earnings Date And Information
Kyntra Bio Inc. last posted its earnings results on Monday, May 11th, 2026. The company reported $-3.74 earnings per share for the quarter, missing analysts' consensus estimates of $-3.36 by $0.38. The company had revenue of 3.74 M for the quarter and had revenue of 6.44 M for the year. Kyntra Bio Inc. has generated $45 earnings per share over the last year ($45.37 diluted earnings per share) and currently has a price-to-earnings ratio of 0.17. Kyntra Bio Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Kyntra Bio Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/12/2026 | Q1 2026 | N/A | -$3.76 | N/A | $1.56 M | $3.74 M |
| 03/16/2026 | Q4 2025 | -$3.89 | -$2.41 | 1.48 | $1.67 M | $1.28 M |
| 11/10/2025 | Q3 2025 | -$4.01 | $49.61 | 53.62 | $2.43 M | $1.08 M |
| 08/11/2025 | Q2 2025 | -$2.25 | -$1.88 | 0.37 | $2.63 M | $1.35 M |
| 05/12/2025 | Q1 2025 | $0.75 | $0.05 | -0.7 | $1.60 M | $2.74 M |
| 03/17/2025 | Q4 2024 | -$0.08 | $4.50 | 4.58 | $24.90 M | $-123,256,000 |
| 11/12/2024 | Q3 2024 | -$0.38 | -$4.25 | -3.87 | $34.84 M | $46.33 M |
| 08/06/2024 | Q2 2024 | -$0.26 | -$3.89 | -3.63 | $34.66 M | $998.00 K |
| 05/06/2024 | Q1 2024 | -$0.31 | -$0.33 | -0.02 | $36.66 M | $25.36 M |
| 02/26/2024 | Q4 2023 | -$0.42 | -$0.57 | -0.15 | N/A | $27.14 M |
| 11/06/2023 | Q3 2023 | -$0.68 | -$0.65 | 0.03 | N/A | $40.13 M |
| 08/07/2023 | Q2 2023 | -$0.72 | -$0.90 | -0.18 | N/A | $44.32 M |
| 05/08/2023 | Q1 2023 | -$0.76 | -$0.81 | -0.05 | N/A | $36.16 M |
| 02/27/2023 | Q4 2022 | -$0.95 | -$0.70 | 0.25 | N/A | $34.37 M |
| 11/07/2022 | Q3 2022 | -$0.83 | -$0.98 | -0.15 | N/A | $15.74 M |
| 08/08/2022 | Q2 2022 | -$0.94 | -$0.78 | 0.16 | N/A | $29.81 M |
| 05/09/2022 | Q1 2022 | -$0.84 | -$0.68 | 0.16 | N/A | $60.83 M |
| 02/28/2022 | Q4 2021 | -$0.68 | -$1.45 | -0.77 | N/A | $16.54 M |
| 11/09/2021 | Q3 2021 | $0.01 | $0.54 | 0.53 | N/A | $155.97 M |
| 08/09/2021 | Q2 2021 | -$0.48 | -$1.45 | -0.97 | N/A | $24.36 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Kyntra Bio Inc. Earnings: FAQ's
The conference call for Kyntra Bio Inc.'s latest earnings report can be listened to online.
The conference call transcript for Kyntra Bio Inc.'s latest earnings report can be read online.
Kyntra Bio Inc. (:KYNB) has a recorded annual revenue of $6.44 M.
Kyntra Bio Inc. (:KYNB) has a recorded net income of $183.45 M.Kyntra Bio Inc. has generated $45.37 earnings per share over the last four quarters.
Kyntra Bio Inc. (:KYNB) has a price-to-earnings ratio of 0.17 and price/earnings-to-growth ratio is 0.